Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Francisco J. Ricart, M.D.
EIR
•Francisco J. Ricart, M.D.•July 16, 2024

Francisco J. Ricart, M.D. – FDA EIR, Jul 16, 2024

Record Details

An unannounced FDA inspection of Francisco J. Ricart, M.D. / CCM Clinical Research Group, located in Miami, FL, was conducted from July 2 to July 16, 2024. This "For Cause" inspection, initiated by the Center for Drug Evaluation and Research, focused on the Clinical Investigator's conduct under the Bioresearch Monitoring Clinical Investigators and Sponsor-Investigators compliance program. The inspection identified significant violations of clinical trial regulations, resulting in an FDA Form 483 with two main observations. First, Dr. Ricart failed to maintain accurate case histories, specifically citing inaccurate transcription of vital sign data from paper source documents into the electronic case report form (eCRF) for 14 out of 18 reviewed subjects. Second, the investigation was not conducted in accordance with the investigational plan, as data entry into the eCRF was not performed in "real-time" or contemporaneously as required by the protocol. Instead, paper source documents were consistently used for initial data capture and then transcribed, without these paper records being uploaded into the eCRF as stipulated. Additional issues noted during management discussions included undated/unsigned progress notes, incomplete paper rater scales, use of whiteout on a source document, and backdating of investigational product temperature logs. Dr. Ricart acknowledged the observations and committed to submitting a written response to the Agency within 15 business days. Regulatory warnings regarding potential agency actions were also provided.

Company
Francisco J. Ricart, M.D.
Inspection date
July 16, 2024
Product type
Drugs
Office
Center for Drug Evaluation and Research
People
  • Angelica M. Chica
  • Francisco J. Ricart (company_representative)
  • Maria D. Gallagher (company_representative)
  • Niurka Alvarez (company_representative)
View Company Profile

ID · 44c6010b-690d-426e-84fe-178bcf053c47

Violation Codes5
21 CFR 312.6021 CFR 5021 CFR 312.62(b)21 CFR 5621 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Francisco J. Ricart, M.D.
  • 483 - 2024-07-16July 16, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Francisco J. Ricart, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.